Home  »  Technologies   »  An Analysis Of Zomedica Corp. (ZOM) Stock...

An Analysis Of Zomedica Corp. (ZOM) Stock

Zomedica Corp. (AMEX:ZOM) has a beta value of 0.82 and has seen 16.74 million shares traded in the last trading session. The company, currently valued at $267.69M, closed the last trade at $0.27 per share which meant it lost -$0.01 on the day or -3.05% during that session. The ZOM stock price is -85.19% off its 52-week high price of $0.50 and 44.44% above the 52-week low of $0.15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 28.93 million shares traded. The 3-month trading volume is 9.71 million shares.

The consensus among analysts is that Zomedica Corp. (ZOM) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Zomedica Corp. (AMEX:ZOM) trade information

Sporting -3.05% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, 01/23/23 when the ZOM stock price touched $0.27 or saw a rise of 19.4%. Year-to-date, Zomedica Corp. shares have moved 65.95%, while the 5-day performance has seen it change 8.24%. Over the past 30 days, the shares of Zomedica Corp. (AMEX:ZOM) have changed 62.85%. Short interest in the company has seen 89.39 million shares shorted with days to cover at 12.23.

Wall Street analysts have a consensus price target for the stock at $6.00, which means that the shares’ value could jump 95.5% from current levels. The projected low price target is $6.00 while the price target rests at a high of $6.00. In that case, then, we find that the current price level is -2122.22% off the targeted high while a plunge would see the stock gain -2122.22% from current levels.

Zomedica Corp. (ZOM) estimates and forecasts

Figures show that Zomedica Corp. shares have outperformed across the wider relevant industry. The company’s shares have gained 6.50% over the past 6 months, with this year growth rate of 60.00%, compared to -2.20% for the industry.

1 have an estimated revenue figure of $1.1 million for the next quarter concluding in Jun 2021.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 23.10% over the past 5 years.

ZOM Dividends

Zomedica Corp. is expected to release its next earnings report between February 23 and February 27 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Zomedica Corp. (AMEX:ZOM)’s Major holders

Insiders own 1.48% of the company shares, while shares held by institutions stand at 9.89% with a share float percentage of 10.04%. Investors are also buoyed by the number of investors in a company, with Zomedica Corp. having a total of 100 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 44.08 million shares worth more than $9.7 million. As of Jun 29, 2022, Vanguard Group, Inc. (The) held 40.80% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 11.35 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $2.5 million and represent 10.51% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 29, 2022, the former fund manager holds about 26.91% shares in the company for having 29.07 million shares of worth $6.4 million while later fund manager owns 13.21 million shares of worth $2.91 million as of Jun 29, 2022, which makes it owner of about 12.22% of company’s outstanding stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

5 Lithium Stocks with High Future Potential

Demand for lithium is expected to increase 8-fold by 2030. The world's largest automakers are racing to go green as the global EV boom continues.

 

We have collated a list of top five lithium stocks which are well positioned to benefit from the 2023 lithium boom because of their focus on multiple high-potential lithium projects.

100% free. stop anytime no spam